Effects of a polyherbal formulation on the quality of life and survival of patients with common upper gastrointestinal cancers: A randomized placebo-controlled trial

Document Type : Original Research Article

Authors

1 Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

2 Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

3 Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran

4 Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran. Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Objective: Previous clinical trials have suggested that herbal medicines can improve the quality of life (QOL) and survival of cancer patients. This study was aimed to evaluate the effects of a polyherbal compound (PHC, formulated as syrup) consisting of Allium sativum, Curcuma longa,Panax ginseng, and Camellia sinensis on the quality of life (QOL) and survival in patients with upper gastrointestinal cancers.
Materials and Methods: A randomized placebo-controlled trial was carried out on patients with esophageal or gastric cancer who had finished their oncological treatments. The patients were randomly assigned to PHC (n=20) or placebo (n=20) group. The PHC group was treated with the PHC for 12 weeks, while the placebo group received 70% sucrose syrup. The QOL was assessed at baseline and after 12 weeks. The patients were followed for up to 24 months to determine overall survival.
Results: PHC significantly improved cancer-related symptoms, physical performance, and psychological and social functions of the patients (p<0.05 for all cases). Death occurred in 33 and 22% of cases in the placebo and PHC group, respectively. The mean survival time was 16.8 months (95% CI: 12.8-20.9) in the placebo group and 21.4 months (95% CI: 19.1-23.6) in the PHC group but the difference was not statistically significant.
Conclusion: The PHC improved cancer-related symptoms, physical performance, and psychological and social functions in patients with gastrointestinal cancers. It seems that this herbal compound has the potential to be used as a supplement in the management of cancer.

Keywords


Aaronson NK, Ahmedzai S, Bergman B,
Bullinger M, Cull A, Duez NJ, Filiberti A,
Flechtner H, Fleishman SB, de Haes JC.
1993. The European Organization for
Research and Treatment of Cancer QLQ-
Fani Pakdel et al.
AJP, Vol. 11, No. 6, Nov-Dec 2021 574
C30: a quality-of-life instrument for use in
international clinical trials in oncology. J
Natl Cancer Inst, 85: 365-376.
Alibeiki F, Jafari N, Karimi M, Dogaheh HP.
2017. Potent anti-cancer effects of less polar
Curcumin analogues on gastric
adenocarcinoma and esophageal squamous
cell carcinoma cells. Sci Rep, 7: 2559.
Bettuzzi S, Brausi M, Rizzi F, Castagnetti G,
Peracchia G, Corti A. 2006.
Chemoprevention of human prostate cancer
by oral administration of green tea catechins
in volunteers with high-grade prostate
intraepithelial neoplasia: a preliminary
report from a one-year proof-of-principle
study. Cancer Res, 66: 1234-1240.
Chung LY, Cheung TC, Kong SK, Fung KP,
Choy YM, Chan ZY, Kwok TT. 2001.
Induction of apoptosis by green tea
catechins in human prostate cancer DU145
cells. Life Sci, 68: 1207-1214.
Cui Y, Shu X-O, Gao Y-T, Cai H, Tao M-H,
Zheng W. 2006. Association of ginseng use
with survival and quality of life among
breast cancer patients. Am J Epidemiol, 163:
645-653.
Derogar M, Lagergren P. 2012. Health-related
quality of life among 5-year survivors of
esophageal cancer surgery: a prospective
population-based study. J Clin Oncol, 30:
413-418.
Erejuwa OO, Sulaiman SA, Wahab MSA.
2014. Effects of honey and its mechanisms
of action on the development and
progression of cancer. Molecules, 19: 2497-
2522.
Fayers P, Aaronson NK, Bjordal K, Grønvold
M, Curran D, Bottomley A. 2001. The
EORTC QLQ-C30 scoring manual 3rd
Edition edn. European Organisation for
Research and Treatment of Cancer,
Brussels.
Ghorbani A, Mohebbati R, Jafarian AH, Vahedi
MM, Hosseini SM, Soukhtanloo M,
Sadeghnia HR. 2016. Toxicity evaluation of
hydroalcoholic extract of Ferula gummosa
root. Regul Toxicol Pharmacol, 77: 35-41.
Gore GG, Satish S, Ganpule A, Srivastava S,
and Athavale M. 2021. Garlic (Allium
sativum) exhibits anticancer and anticancer
stem cell activity on breast, prostate, colon,
hepatic and cervical cancer cell lines. Int J
Herbal Med, 9: 93-99.
Hosseini A, Ghorbani A. 2015. Cancer therapy
with phytochemicals: evidence from clinical
studies. Avicenna J Phytomed, 5: 84-97.
Hosseini A, Mollazadeh H, Amiri MS,
Sadeghnia HR, Ghorbani A. 2017. Effects
of a standardized extract of Rheum
turkestanicum Janischew root on diabetic
changes in the kidney, liver and heart of
streptozotocin-induced diabetic rats.
Biomed Pharmacother, 86: 605-611.
Hwang IC, Yun YH, Kim Y-W, Ryu KW, Kim
YA, Kim S, Bae J-M, Noh J-H, Sohn T-S.
2014. Factors related to clinically relevant
fatigue in disease-free stomach cancer
survivors and expectation–outcome
consistency. Supportive Care Cancer, 22:
1453-1460.
Jemal A, Ward EM, Johnson CJ, Cronin KA,
Ma J, Ryerson AB, Mariotto A, Lake AJ,
Wilson R, Sherman RL. 2017. Annual report
to the nation on the status of cancer, 1975–
2014, featuring survival. J Natl Cancer Inst.
109: djx030.
Jiao L, Bi L, Lu Y, Wang Q, Gong Y, Shi J, Xu
L. 2018. Cancer chemoprevention and
therapy using chinese herbal medicine. Biol
Proced Online, 20: 1-14.
Karanicolas PJ, Graham D, Gönen M, Strong
VE, Brennan MF, Coit DG. 2013. Quality of
life after gastrectomy for adenocarcinoma: a
prospective cohort study. Ann Surg, 257:
1039-1046.
Kim JH, Park CY, Lee SJ. 2006. Effects of Sun
Ginseng on subjective quality of life in
cancer patients: a double‐blind, placebo‐
controlled pilot trial. J Clin Pharm Ther, 31:
331-334.
Korenaga D, Orita H, Okuyama T, Moriguchi
S, Maehara Y, Sugimachi K. 1992. Quality
of life after gastrectomy in patients with
carcinoma of the stomach. Br J Surg, 79:
248-250.
Lenartz D, Dott U, Menzel J, Schierholz J,
Beuth J. 2000. Survival of glioma patients
after complementary treatment with
galactoside-specific lectin from mistletoe.
Anticancer Res, 20: 2073-2076.
Montazeri A, Harirchi I, Vahdani M, Khaleghi
F, Jarvandi S, Ebrahimi M, Haji-Mahmoodi
M. 1999. The European Organization for
Research and Treatment of Cancer Quality
of Life Questionnaire (EORTC QLQ-C30):
translation and validation study of the
Iranian version. Support Care in Cancer, 7:
400-406.
Njei B, McCarty TR, Birk JW. 2016. Trends in
esophageal cancer survival in United States
Effects of a polyherbal formulation on gastrointestinal cancers
AJP, Vol. 11, No. 6, Nov-Dec 2021 575
adults from 1973 to 2009: a SEER database
analysis. J Gastroenterol Hepatol, 31: 1141-
1146.
Numico G, Longo V, Courthod G, Silvestris N.
2015. Cancer survivorship: long-term sideeffects of anticancer treatments of
gastrointestinal cancer. Curr Opin Oncol,
27: 351-357.
Panahi Y, Saadat A, Beiraghdar F, Sahebkar A.
2014. Adjuvant therapy with bioavailability‐
boosted curcuminoids suppresses systemic
inflammation and improves quality of life in
patients with solid tumors: a randomized
double‐blind placebo‐controlled trial.
Phytother Res, 28: 1461-1467.
Piao B, Wang Y, Xie G, Mansmann U, Matthes
H, Beuth J, Lin H. 2004. Impact of
complementary mistletoe extract treatment
on quality of Life in breast, ovarian and nonsmall cell lung cancer patients a prospective
randomized controlled clinical trial.
Anticancer Res, 24: 303-310,
Saklani A, Kutty SK. 2008. Plant-derived
compounds in clinical trials. Drug Discov
Today, 13: 161-171.
Singh V. 2017. Effect of application of honey
in chemoradiation-induced mucositis and to
assess its clinical benefits in improving
quality of life in patients of head and neck
cancer. Int J Oral Maxillofac Surg, 46: 248-
249.
Strong VE, Wu Aw, Selby LV, Gonen M, Hsu
M, Song KY, Park CH, Coit DG, Ji Jf,
Brennan MF. 2015. Differences in gastric
cancer survival between the US and China.
J Surg Oncol, 112: 31-37.
Suh SO, Kroh M, Kim NR, Joh YG, Cho MY.
2002. Effects of red ginseng upon
postoperative immunity and survival in
patients with stage III gastric cancer. Am J
Chin Med, 30: 483-494.
Tanaka S, Haruma K, Yoshihara M, Kajiyama
G, Kira K, Amagase H, Chayama K. 2006.
Aged garlic extract has potential suppressive
effect on colorectal adenomas in humans. J
Nutr, 136: 821S-826S.
Tantoy IY, Cooper BA, Dhruva A, Cataldo J,
Paul SM, Conley YP, Hammer M, Kober
KM, Levine JD, Miaskowski C. 2018.
Quality of life of patients with
gastrointestinal cancers undergoing
chemotherapy. Qual Life Res, 27: 1865-
1876.
WHO. 2018. WHO key facts about cancer.
Available from
http://www.who.int/en/news-room/factsheets/detail/cancer [Accessed on 1
February 2018].
Zaid H, Silbermann M, Amash A, Gincel D,
Abdel-Sattar E, Sarikahya NB. 2017.
Medicinal plants and natural active
compounds for cancer
chemoprevention/chemotherapy. Evid
Based Complement Alternat Med, 2017:
7952417.
Zhu H, Liu H, Zhu JH, Wang SY, Zhou SS,
Kong M, Mao Q, Long F, Fang ZJ, Li SL.
2021. Efficacy of ginseng and its ingredients
as adjuvants to chemotherapy in non-small
cell lung cancer. Food Funct, 12: 2225-
2241.